Buy or sell Nuvaira stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Nuvaira Stock
Develops devices for treating lung diseases
About Nuvaira Stock
Nuvaira, Inc. (formerly Holaira, Inc.), located in Minneapolis, Minnesota is a privately held lung denervation company developing minimally invasive products that aims to make breathing easier for patients suffering from obstructive lung diseases.
Funding History
| September 2010 | $3.0M |
|---|---|
| May 2011 | $5.0M |
| September 2012 | $10.6M |
| February 2013 | $10.0M |
| April 2014 | $40.0M |
| February 2019 | $79.0M |
Management
President and CEO
Dennis Wahr
Founder & CTO
Martin L. Mayse
Director of Regulatory Affairs
Mahtab Fatemi
Vice President Clinical Affairs
Jim Pavliska
CFO
Kari Kubesh
Senior Vice President Operations
Steve Mertens
Board of Directors, President and CEO
Dennis W. Wahr
Vice President International Development
Scott Grant
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
